Darunavir

Description

Darunavir is an antiviral medicine used along with ritonavir to treat human immunodeficiency virus (HIV). This medicine is not a cure for HIV. It only prevents the virus from multiplying in your body. This medicine is not recommended for use in children under the age of 3 years.

Side effects

Major & minor side effects for Darunavir

  • Skin Rash
  • Sweating
  • Stomach pain
  • Diarrhea
  • Dry mouth
  • Nausea and Vomiting
  • Headache
  • Runny Nose

Uses of Darunavir

What is it prescribed for?

  • HIV infection
Read More
Concerns

Commonly asked questions

  • Onset of action
    The time required for this medicine to show its effect is not clinically established.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 12 hours.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendency has been reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is recommended for use in breastfeeding women only in life-threatening conditions. The risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to darunavir.

Drug interaction

This medicine is not recommended for use in patients receiving medicines which are highly dependent on CYP3A for their clearance as well as strong CYP3A inducers due to an alteration in Darunavir blood levels which may cause serious and life-threatening reactions.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is recommended for use in breastfeeding women only in life-threatening conditions. The risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Hepatotoxicity

Darunavir should be used with caution in patients with a history of liver disease and active liver disease. Report to the doctor if any unusual symptoms appear. The dose of the medicine should be adjusted based on the clinical condition.

Fat redistribution

Darunavir may cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority.

Pancreatitis

Darunavir may cause pancreatitis in some patients. Report to the doctor if any unusual symptoms appear. The dose of the medicine should be adjusted based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember it. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amlodipine

Cisapride

Glipizide

Midazolam

Cyclosporine

Dutasteride

Disease interactions

Hepatotoxicity

Darunavir should be used with extreme caution in patients with liver disease. Liver function should be assessed before initiating the treatment. The dose should be adjusted based on the severity of the liver disease.

Hyperglycemia

This medicine should be used with caution due to the risk of an increase in the blood glucose levels. Blood glucose levels should be monitored closely during the treatment with this medicine. Patients with diabetes should be carefully monitored for symptoms like increased frequency of urination, excessive thirst, etc. If necessary, the dose of the antidiabetic agents should be adjusted based on the clinical condition.

Hemophilia

This medicine should be used with caution in patients with a known history of bleeding disorders due to the increased risk of excessive bleeding. Close monitoring of INR or prothrombin time is necessary for such patients. Appropriate dose adjustments or replacement with a suitable alternative should be done under your doctor's supervision.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Darunavir exactly as instructed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that proper hygiene measures are adopted. Complete the course of treatment to prevent the spread of the infection. Close monitoring of liver function and blood glucose levels is necessary while receiving this medicine.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
It works by stopping the human immunodeficiency virus (HIV) from multiplying. This helps in reducing the chances of development of acquired immunodeficiency syndrome (AIDS) and other HIV-related illnesses.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Protease inhibitors

Schedule

Schedule H

DailyMed - PREZISTA- darunavir tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 3 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4aa9007-1afb-4486-b323-33aadcd0b933

Darunavir - DrugBank [Internet]. Drugbank.ca. 2017 [cited 3 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB01264

Darunavir: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 3 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a607042.html

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 3 August 2017]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 10 Aug 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.